Calcipotriol - Drug Delivery Solutions ApS

Drug Profile

Calcipotriol - Drug Delivery Solutions ApS

Alternative Names: MC2 04; MC2-16; PADcalci

Latest Information Update: 24 Sep 2015

Price : $50

At a glance

  • Originator Drug Delivery Solutions ApS
  • Class Antipsoriatics; Cyclohexanes; Dihydroxycholecalciferols; Indenes; Vitamin D analogues
  • Mechanism of Action Calcitriol receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Plaque psoriasis

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 08 May 2015 Drug Delivery Solutions completes a phase II trial in Plaque psoriasis in Germany (EudraCT2013-005003-14)
  • 02 Apr 2014 Phase-II clinical trials in Plaque psoriasis in Germany (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top